Olga A. Egorova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga A. Egorova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr A. Tarasov
Smolensk State Medical University
4 shared publications Russian Federation Smolensk Regional Clinical Hospital. 214018
2 shared publicationsSmolensk Smolensk Regional Clinical Hospital
2 shared publicationsЕгорова Ольга Анатольевна
ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России
2 shared publicationsA.A. Tarasov Tarasov
1 shared publication- Albina V. Dobrotok
Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery
1 shared publication
Latest Publications
- Open Access
- 5 October 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (9) , 752-759
Relevant and universal methods of managing patients with acute rhinosinusitis. How to avoid complications? A review
Acute rhinosinusitis is one of the most common conditions encountered in outpatient practice. In Russia, 30–40 million cases of acute upper respiratory tract infections are recorded annually; however, the actual number of cases is higher due to the widespread practice of self-medication. Its high prevalence presents a significant medical, social, and economic challenge: the disease impairs patients' quality of life and ability to work, places a burden on the healthcare system, and carries the risk of severe, potentially life-threatening complications (such as meningitis, abscesses, and orbital cellulitis) that often require surgical intervention. Patients with acute rhinosinusitis account for up to 20% of admissions to ENT hospital departments, while the incidence of orbital and intracranial complications ranges from 3% to 20%. According to the EPOS 2020 (European Position Paper on Rhinosinusitis and Nasal Polyps) classification, acute rhinosinusitis is categorized into three forms: viral, post-viral, and bacterial. Notably, the bacterial form occurs in only 0.5–2% of patients, whereas the majority of cases are of viral origin. The primary goals of therapy are symptom relief, reduction of disease duration, and prevention of complications. This article reviews scientific literature, systematizing current treatment principles for acute rhinosinusitis and evaluating the role of various therapeutic approaches within clinical algorithms, including an analysis of their efficacy, limitations, and potential risks. Particular attention is given to the use of the herbal preparation Sinupret® Extract – a dry native extract derived from five medicinal plants which exhibits secretolytic, anti-inflammatory, antiviral, and antimicrobial properties. Clinical study results are presented, confirming that its use facilitates faster symptom resolution, improves mucociliary clearance, reduces the need for antibiotics, and shortens the period of work incapacity. Based on the data presented, the drug can be considered as an option for initial monotherapy for viral rhinosinusitis, as a key component of combination therapy for post-viral rhinosinusitis, and as an adjunct to antibiotic therapy for the bacterial form. This approach helps minimize the unnecessary use of antibacterial agents and reduce the risk of complications.
- 5 October 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (9) , 752-759
Open AccessRelevant and universal methods of managing patients with acute rhinosinusitis. How to avoid complications? A review
Acute rhinosinusitis is one of the most common conditions encountered in outpatient practice. In Russia, 30–40 million cases of acute upper respiratory tract infections are recorded annually; however, the actual number of cases is higher due to the widespread practice of self-medication. Its high prevalence presents a significant medical, social, and economic challenge: the disease impairs patients' quality of life and ability to work, places a burden on the healthcare system, and carries the risk of severe, potentially life-threatening complications (such as meningitis, abscesses, and orbital cellulitis) that often require surgical intervention. Patients with acute rhinosinusitis account for up to 20% of admissions to ENT hospital departments, while the incidence of orbital and intracranial complications ranges from 3% to 20%. According to the EPOS 2020 (European Position Paper on Rhinosinusitis and Nasal Polyps) classification, acute rhinosinusitis is categorized into three forms: viral, post-viral, and bacterial. Notably, the bacterial form occurs in only 0.5–2% of patients, whereas the majority of cases are of viral origin. The primary goals of therapy are symptom relief, reduction of disease duration, and prevention of complications. This article reviews scientific literature, systematizing current treatment principles for acute rhinosinusitis and evaluating the role of various therapeutic approaches within clinical algorithms, including an analysis of their efficacy, limitations, and potential risks. Particular attention is given to the use of the herbal preparation Sinupret® Extract – a dry native extract derived from five medicinal plants which exhibits secretolytic, anti-inflammatory, antiviral, and antimicrobial properties. Clinical study results are presented, confirming that its use facilitates faster symptom resolution, improves mucociliary clearance, reduces the need for antibiotics, and shortens the period of work incapacity. Based on the data presented, the drug can be considered as an option for initial monotherapy for viral rhinosinusitis, as a key component of combination therapy for post-viral rhinosinusitis, and as an adjunct to antibiotic therapy for the bacterial form. This approach helps minimize the unnecessary use of antibacterial agents and reduce the risk of complications.
- Open Access
- 30 May 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (3) , 140-147
Clinical experience of a comprehensive approach for symptomatic treatment of inflammatory diseases of the throat. Case report.
Pharyngeal diseases play a leading role in the structure of seeking ENT care, and sore throat is one of the most common complaints when a patient visits an otorhinolaryngologist. There are many possible causes of sore throat. Acute pain is more often associated with acute inflammation of the pharyngeal mucosa caused by microorganisms (viruses, bacteria, fungi) or injury. In chronic pain, non-infectious factors are more important: environmental conditions, bad habits, concomitant diseases, and taking medications. But whatever the nature of the pain, when contacting a doctor, patients primarily expect treatment that can remove the pain component. Therefore, choosing an effective and safe drug is an important task. For diseases accompanied by sore throat, a wide range of medications belonging to various groups (antiseptics, antibiotics, local anesthetics, etc.) is used. One of these groups with pathogenic effects is the group of nonsteroidal anti-inflammatory drugs (NSAIDs). The work demonstrates the effectiveness of using domestic drugs from the group of topical NSAIDs Ketoprofen-LOR gargle solution and Flurbiprofen-Pharmstandard lozenge in patients with infectious diseases of the pharynx. A retrospective analysis of three clinical cases of drug use in patients with herpangina and acute tonsillitis was performed. The high effectiveness of the drugs in relieving pain was shown, and it was noted that the combination of drugs provided a stable analgesic effect, allowing for confident control of even severe pain throughout the day. The combination of the two drugs demonstrated good tolerability, and no adverse reactions were reported. It is concluded that the drugs Ketoprofen-LOR and Flurbiprofen-Pharmstandard in combination and individually are convenient, effective and safe medications for the symptomatic treatment of pain associated with inflammatory diseases of the pharynx. The described cases are accompanied by a literature overview reflecting the worldwide experience of using local NSAIDs for sore throat. It is shown that the results and conclusions obtained in the work correspond to the data demonstrated in other studies.
- 30 May 2026
- Published by Consilium Medicum in Consilium Medicum
- Vol. 28 (3) , 140-147
Open AccessClinical experience of a comprehensive approach for symptomatic treatment of inflammatory diseases of the throat. Case report.
Pharyngeal diseases play a leading role in the structure of seeking ENT care, and sore throat is one of the most common complaints when a patient visits an otorhinolaryngologist. There are many possible causes of sore throat. Acute pain is more often associated with acute inflammation of the pharyngeal mucosa caused by microorganisms (viruses, bacteria, fungi) or injury. In chronic pain, non-infectious factors are more important: environmental conditions, bad habits, concomitant diseases, and taking medications. But whatever the nature of the pain, when contacting a doctor, patients primarily expect treatment that can remove the pain component. Therefore, choosing an effective and safe drug is an important task. For diseases accompanied by sore throat, a wide range of medications belonging to various groups (antiseptics, antibiotics, local anesthetics, etc.) is used. One of these groups with pathogenic effects is the group of nonsteroidal anti-inflammatory drugs (NSAIDs). The work demonstrates the effectiveness of using domestic drugs from the group of topical NSAIDs Ketoprofen-LOR gargle solution and Flurbiprofen-Pharmstandard lozenge in patients with infectious diseases of the pharynx. A retrospective analysis of three clinical cases of drug use in patients with herpangina and acute tonsillitis was performed. The high effectiveness of the drugs in relieving pain was shown, and it was noted that the combination of drugs provided a stable analgesic effect, allowing for confident control of even severe pain throughout the day. The combination of the two drugs demonstrated good tolerability, and no adverse reactions were reported. It is concluded that the drugs Ketoprofen-LOR and Flurbiprofen-Pharmstandard in combination and individually are convenient, effective and safe medications for the symptomatic treatment of pain associated with inflammatory diseases of the pharynx. The described cases are accompanied by a literature overview reflecting the worldwide experience of using local NSAIDs for sore throat. It is shown that the results and conclusions obtained in the work correspond to the data demonstrated in other studies.
- Open Access
- 10 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- Vol. 19 (13) , 108-114
Clinical experience of pain management in infectious and inflammatory diseases of pharynx
The article presents clinical cases that focus on administration of ketoprofen as a throat wash and flurbiprofen as lozenges in a child with acute viral tonsillopharyngitis and two adult patients with peritonsillar abscesses. The drugs have been shown to provide a rapid and strong analgesic effect. Patients reported a significant reduction in pain within 10–20 minutes after administration of the drugs. It was emphasized that the combined use of a throat wash and lozenges produced a faster effect as compared to the single-drug therapy. The patient with a peritonsillar abscess who received a combination of two drugs demonstrated a complete relief of sore throat a day earlier than a patient who only received lozenges as pain relief therapy. No adverse reactions to the drugs were observed in patients. The presented cases are accompanied by a literature review, which provides information on the epidemiology, causes and mechanisms, as well as methods for treating a sore throat. Otolaryngologists most often see patients with nociceptive pain caused by an infectious and inflammatory factor in their practice. A wide range of drugs from various groups (antiseptics, antibiotics, local anesthetics, etc.) are used to relieve pain, but only a group of non-steroidal anti-inflammatory drugs has a pathogenetic effect.
- 10 September 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- Vol. 19 (13) , 108-114
Open AccessClinical experience of pain management in infectious and inflammatory diseases of pharynx
The article presents clinical cases that focus on administration of ketoprofen as a throat wash and flurbiprofen as lozenges in a child with acute viral tonsillopharyngitis and two adult patients with peritonsillar abscesses. The drugs have been shown to provide a rapid and strong analgesic effect. Patients reported a significant reduction in pain within 10–20 minutes after administration of the drugs. It was emphasized that the combined use of a throat wash and lozenges produced a faster effect as compared to the single-drug therapy. The patient with a peritonsillar abscess who received a combination of two drugs demonstrated a complete relief of sore throat a day earlier than a patient who only received lozenges as pain relief therapy. No adverse reactions to the drugs were observed in patients. The presented cases are accompanied by a literature review, which provides information on the epidemiology, causes and mechanisms, as well as methods for treating a sore throat. Otolaryngologists most often see patients with nociceptive pain caused by an infectious and inflammatory factor in their practice. A wide range of drugs from various groups (antiseptics, antibiotics, local anesthetics, etc.) are used to relieve pain, but only a group of non-steroidal anti-inflammatory drugs has a pathogenetic effect.
- 6 December 2023
- Published by Open Systems Publications in Лечащий врач
- No. 12(26)
The problem of deficiency of factors of the anticoagulant system. Clinical case
Background. In available foreign publications, there is evidence of a high incidence of mortality in the development of septic conditions in children in case of deficiency of factors in the natural anticoagulant system. It is known that deficiency of factors in the anticoagulant system can be congenital and acquired. Congenital deficiency is quite rare, and acquired deficiency can be observed against the background of inflammatory reactions in chronic, infectious diseases, oncopathology. Of particular concern is the lack of proper attention to patients of children's age category, the clinical picture of thrombosis in which may be erased. At the same time, it is in children that timely diagnosis and prevention, as well as identifying the presence of a risk of such events, can play a key role in preventing disability. Severe complications of physiological anticoagulant deficiency are thrombotic events and skin necrosis. The presented clinical case describes an episode of acquired protein S deficiency in a child. Objective. To analyse a diagnostically complex clinical case from real medical practice in order to draw attention to the problem of acquired physiological anticoagulant deficiency against the background of bacterial complications after viral infection in children. Materials and methods. The article describes a clinical case of acquired deficiency of the anti-clotting system factor complicated by the development of DIC, skin necrosis and venous thrombosis of the lower limbs after a viral infection in a young child. The peculiarity of this case is the debut of the disease with skin lesions of the extremities against the background of the development of disorders in the platelet and plasma links of haemostasis with a developing deficiency of components of the plasma link of haemostasis. To establish the diagnosis, the patient underwent an in-depth study of the haemostasis system to clarify the deficiency of factors of the natural anticoagulant system (protein C, protein S, antithrombin III). Conclusion. This clinical observation shows the importance of careful history taking and the necessity of timely examination of the patient when bacterial complications develop after a viral infection. The clinical case also demonstrates the importance of multidisciplinary approach and continuity between doctors of different specialities in the diagnosis of severe disorders of coagulation and anti-coagulation systems, which contributes to adequate assessment of the detected disorders, prediction of the risk of possible complications (haemorrhagic and thrombotic syndromes), and preservation of patients' quality of life.
- 6 December 2023
- Published by Open Systems Publications in Лечащий врач
- No. 12(26)
The problem of deficiency of factors of the anticoagulant system. Clinical case
Background. In available foreign publications, there is evidence of a high incidence of mortality in the development of septic conditions in children in case of deficiency of factors in the natural anticoagulant system. It is known that deficiency of factors in the anticoagulant system can be congenital and acquired. Congenital deficiency is quite rare, and acquired deficiency can be observed against the background of inflammatory reactions in chronic, infectious diseases, oncopathology. Of particular concern is the lack of proper attention to patients of children's age category, the clinical picture of thrombosis in which may be erased. At the same time, it is in children that timely diagnosis and prevention, as well as identifying the presence of a risk of such events, can play a key role in preventing disability. Severe complications of physiological anticoagulant deficiency are thrombotic events and skin necrosis. The presented clinical case describes an episode of acquired protein S deficiency in a child. Objective. To analyse a diagnostically complex clinical case from real medical practice in order to draw attention to the problem of acquired physiological anticoagulant deficiency against the background of bacterial complications after viral infection in children. Materials and methods. The article describes a clinical case of acquired deficiency of the anti-clotting system factor complicated by the development of DIC, skin necrosis and venous thrombosis of the lower limbs after a viral infection in a young child. The peculiarity of this case is the debut of the disease with skin lesions of the extremities against the background of the development of disorders in the platelet and plasma links of haemostasis with a developing deficiency of components of the plasma link of haemostasis. To establish the diagnosis, the patient underwent an in-depth study of the haemostasis system to clarify the deficiency of factors of the natural anticoagulant system (protein C, protein S, antithrombin III). Conclusion. This clinical observation shows the importance of careful history taking and the necessity of timely examination of the patient when bacterial complications develop after a viral infection. The clinical case also demonstrates the importance of multidisciplinary approach and continuity between doctors of different specialities in the diagnosis of severe disorders of coagulation and anti-coagulation systems, which contributes to adequate assessment of the detected disorders, prediction of the risk of possible complications (haemorrhagic and thrombotic syndromes), and preservation of patients' quality of life.
- Open Access
- 17 May 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 68-76
Local therapy of sore throat against the background of antibiotic resistance
Sore throat is an acutely common health problem both in Russia and around the world as a whole. This is one of the most common reasons adults and children seek primary specialized care. The overuse and misuse of antibiotics, especially for viral infections of the respiratory tract, such as acute and exacerbation of chronic tonsillopharyngitis, greatly increases the risk of developing and spreading antibiotic resistance. Up to 80% of cases of sore throat have a viral etiology of the disease, and even when the infection is bacterial, except for pyogenic streptococcus, the vast majority of cases do not require systemic antibiotic therapy. However, antibiotics are still often and unreasonably prescribed to treat sore throats. In addition, topical antibiotics for sore throats are widely available over the counter over the counter. The clinical guidelines for the treatment of acute tonsillopharyngitis indicate that systemic antibiotic therapy is indicated for patients with sore throat of streptococcal etiology. Considering the growing antibiotic resistance in the world, much attention is paid to over-the-counter treatment of sore throat, which does not contain antibiotics in its composition, namely, the appointment of local anti-inflammatory drugs that can prevent the further development of the infectious process in the throat. The combined local and systemic effects, achieved through local delivery of flurbiprofen to the inflamed tissues in throat, have led to the development of flurbiprofen 8.75 mg in different types of dosage forms (including lozenges and sprays) to treat a sore throat.
- 17 May 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 68-76
Open AccessLocal therapy of sore throat against the background of antibiotic resistance
Sore throat is an acutely common health problem both in Russia and around the world as a whole. This is one of the most common reasons adults and children seek primary specialized care. The overuse and misuse of antibiotics, especially for viral infections of the respiratory tract, such as acute and exacerbation of chronic tonsillopharyngitis, greatly increases the risk of developing and spreading antibiotic resistance. Up to 80% of cases of sore throat have a viral etiology of the disease, and even when the infection is bacterial, except for pyogenic streptococcus, the vast majority of cases do not require systemic antibiotic therapy. However, antibiotics are still often and unreasonably prescribed to treat sore throats. In addition, topical antibiotics for sore throats are widely available over the counter over the counter. The clinical guidelines for the treatment of acute tonsillopharyngitis indicate that systemic antibiotic therapy is indicated for patients with sore throat of streptococcal etiology. Considering the growing antibiotic resistance in the world, much attention is paid to over-the-counter treatment of sore throat, which does not contain antibiotics in its composition, namely, the appointment of local anti-inflammatory drugs that can prevent the further development of the infectious process in the throat. The combined local and systemic effects, achieved through local delivery of flurbiprofen to the inflamed tissues in throat, have led to the development of flurbiprofen 8.75 mg in different types of dosage forms (including lozenges and sprays) to treat a sore throat.
- 1 March 2022
- Published by Bionika Media in Pharmateca
- Vol. 1_2022
Ear hygiene and helping to dissolve cerumen plugs in children
- 1 March 2022
- Published by Bionika Media in Pharmateca
- Vol. 1_2022
Ear hygiene and helping to dissolve cerumen plugs in children
- 26 October 2021
- Published by Open Systems Publications in Лечащий врач
- No. 10(24)
Acute otitis medium complicated by mastoiditis in a child after a possible new coronoviral infection: a clinical case
The article describes a clinical case of acute otitis media in an 8-year-old child complicated by mastoiditis, antibodies to SARS-CoV-2 and IgG coronovirus were detected in the child's blood. The data available today indicate that children make up up to 10% in the structure of infected SARS-CoV-2 and up to 2% in the structure of patients with diagnosed clinical cases of COVID-19. In the Russian Federation, children account for 6-7% of the registered cases of COVID-19. At the beginning of the pandemic, it was revealed that children have a lighter course of the disease and complications and unfavorable outcomes are much less common. However, in the following months, clinicians began to note a multiple increase in the frequency of hospitalization of children for COVID-19. The described case shows the rapid development of acute mastoiditis with the destruction of the outer plate of the temporal bone in a child, as a complication of acute otitis media, after a new coronavirus infection. The article presents information on the relevance of epidemiology, clinical picture, diagnosis and treatment of acute otitis media complicated by mastoiditis in children. It should be emphasized that in order to achieve the most effective tactics of introducing patients, close cooperation of doctors of narrow specialties with pediatricians is necessary, mass testing of the child population, further research to obtain reliable data on the impact of a new coronavirus infection on the child's body. Currently, there is insufficient data in the available literature on the effect of COVID-19 on ENT organs in children. In this regard, further studies on ENT diseases in this category of patients are needed on the background of or after a COVID-19 infection.
- 26 October 2021
- Published by Open Systems Publications in Лечащий врач
- No. 10(24)
Acute otitis medium complicated by mastoiditis in a child after a possible new coronoviral infection: a clinical case
The article describes a clinical case of acute otitis media in an 8-year-old child complicated by mastoiditis, antibodies to SARS-CoV-2 and IgG coronovirus were detected in the child's blood. The data available today indicate that children make up up to 10% in the structure of infected SARS-CoV-2 and up to 2% in the structure of patients with diagnosed clinical cases of COVID-19. In the Russian Federation, children account for 6-7% of the registered cases of COVID-19. At the beginning of the pandemic, it was revealed that children have a lighter course of the disease and complications and unfavorable outcomes are much less common. However, in the following months, clinicians began to note a multiple increase in the frequency of hospitalization of children for COVID-19. The described case shows the rapid development of acute mastoiditis with the destruction of the outer plate of the temporal bone in a child, as a complication of acute otitis media, after a new coronavirus infection. The article presents information on the relevance of epidemiology, clinical picture, diagnosis and treatment of acute otitis media complicated by mastoiditis in children. It should be emphasized that in order to achieve the most effective tactics of introducing patients, close cooperation of doctors of narrow specialties with pediatricians is necessary, mass testing of the child population, further research to obtain reliable data on the impact of a new coronavirus infection on the child's body. Currently, there is insufficient data in the available literature on the effect of COVID-19 on ENT organs in children. In this regard, further studies on ENT diseases in this category of patients are needed on the background of or after a COVID-19 infection.
- Open Access
- 15 June 2021
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 170-176
The use of decongestants in children in otorhinolaryngological practice
The data about the prevalence of ENT organ diseases in children and the necessity of prescription of nasal forms of vasoconstrictors (decongestants) are presented. A review of the data about the mechanism of action of decongestants, safety and evidence base of their effectiveness in treatment of otorhinolaryngological diseases is presented. It is concluded that decongestants with a higher safety level are chosen a modern combined preparation containing antihistamine (dimethinden) and vasoconstrictor (phenylephrine) components.
- 15 June 2021
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 170-176
Open AccessThe use of decongestants in children in otorhinolaryngological practice
The data about the prevalence of ENT organ diseases in children and the necessity of prescription of nasal forms of vasoconstrictors (decongestants) are presented. A review of the data about the mechanism of action of decongestants, safety and evidence base of their effectiveness in treatment of otorhinolaryngological diseases is presented. It is concluded that decongestants with a higher safety level are chosen a modern combined preparation containing antihistamine (dimethinden) and vasoconstrictor (phenylephrine) components.
- 21 May 2019
- Published by Bionika Media in Pharmateca
- Vol. 5_2019
Macrolide antibiotic roxitromycin - the main clinical and pharmacological aspects of application
- 21 May 2019
- Published by Bionika Media in Pharmateca
- Vol. 5_2019
Macrolide antibiotic roxitromycin - the main clinical and pharmacological aspects of application
- Open Access
- 1 January 2018
- Published by Consilium Medicum in Consilium Medicum
- Vol. 18 (11)
The importance of local anti-inflammatory drugs in the initial treatment of sore throat
Frequency assignment of antibacterial drugs in the treatment of sore throat in Russia is unreasonably high. Sore throat is one of the most common reasons for visits to doctors for outpatient reception. Purpose of systemic antibiotic therapy is justified only in the case of streptococcal disease etiology. Much attention is paid to the early appointment of the local anti-inflammatory drugs, can prevent further infection. The basic requirements are met by the drug Strepsils Intensive, which not only helps to relieve pain in the throat, but also acts on the cause – inflammation. Strepsils Intensive has a dual action: anti-inflammatory, analgesic. Key words: sore throat, acute tonsillofaringitis, a local anti-inflammatory therapy, Strepsils Intensive. For citation: Egorova O.A. The importance of local anti-inflammatory drugs in the initial treatment of sore throat. Consilium Medicum. 2016; 18 (11): 67–72.DOI:10.26442/2075-1753_2016.11.67-72
- 1 January 2018
- Published by Consilium Medicum in Consilium Medicum
- Vol. 18 (11)
Open AccessThe importance of local anti-inflammatory drugs in the initial treatment of sore throat
Frequency assignment of antibacterial drugs in the treatment of sore throat in Russia is unreasonably high. Sore throat is one of the most common reasons for visits to doctors for outpatient reception. Purpose of systemic antibiotic therapy is justified only in the case of streptococcal disease etiology. Much attention is paid to the early appointment of the local anti-inflammatory drugs, can prevent further infection. The basic requirements are met by the drug Strepsils Intensive, which not only helps to relieve pain in the throat, but also acts on the cause – inflammation. Strepsils Intensive has a dual action: anti-inflammatory, analgesic. Key words: sore throat, acute tonsillofaringitis, a local anti-inflammatory therapy, Strepsils Intensive. For citation: Egorova O.A. The importance of local anti-inflammatory drugs in the initial treatment of sore throat. Consilium Medicum. 2016; 18 (11): 67–72.DOI:10.26442/2075-1753_2016.11.67-72